DAM
HELP

DLD Asset Management’s Helus Pharma Inc. Common Stock HELP Stock Holding History

DLD Asset Management’s Portfolio HELP Stock Details HELP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-80,000
Closed -$515K – 399
2025
Q3 		$471K Buy
+80,000
New +$567K 0.03% 219

Other funds holding HELP

VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

DLD Asset Management's HELP Position: Q4 2025 in Review

DLD Asset Management sold out of Helus Pharma Inc. Common Stock (HELP) in Q4 2025, closing a stake of 80,000 shares — an estimated $515K sold.

DLD Asset Management first reported a position in HELP in Q3 2025 and held it in 1 quarter. The position peaked at $471K in Q3 2025. 80 funds tracked by Wall St. Rank hold HELP as of Q4 2025.

  • DLD Asset Management reported no remaining Helus Pharma Inc. Common Stock position as of Q4 2025 after selling out during the quarter.
  • DLD Asset Management sold 80,000 Helus Pharma Inc. Common Stock shares in Q4 2025, an estimated $515K.
  • DLD Asset Management first reported a position in Helus Pharma Inc. Common Stock in Q3 2025 and held it in 1 quarter.
  • DLD Asset Management's Helus Pharma Inc. Common Stock position peaked at $471K in Q3 2025.
  • 80 funds tracked by Wall St. Rank held Helus Pharma Inc. Common Stock as of Q4 2025.

Based on DLD Asset Management's 13F filing for Q4 2025, filed 13 Feb 2026.